Life Science Washington News | Life Science Washington - Part 3

Filter by

Funding

In Washington’s Life Sciences Sector, A Streak of Companies Going Public

Posted onAugust 9, 2021 Last Updated: August 9, 2021
By: Kaitlyn Grosse

Funding

Icosavax Stock Skyrockets 200% on First Day of Trading for Newly Public Seattle Biotech Company

Posted onAugust 2, 2021 Last Updated: August 2, 2021
By: Kaitlyn Grosse

COVID

‘We’ve been instrumental’: How Seattle Became a Hub for COVID-19 Vaccine Research

Posted onAugust 2, 2021 Last Updated: August 2, 2021
By: Kaitlyn Grosse

News

Life Science Washington Announces Retirement of President and CEO, Dr. Leslie Alexandre

Posted onJuly 27, 2021 Last Updated: July 27, 2021
By: Kaitlyn Grosse

Funding

Absci Shares Spike 30% in IPO Debut, Valuing Washington State Biotech Company at Nearly $2B

Posted onJuly 26, 2021 Last Updated: July 26, 2021
By: Kaitlyn Grosse

Funding

Eliem Therapeutics Files for IPO as Another Seattle-Area Biotech Firm Set to Go Public

Posted onJuly 26, 2021 Last Updated: July 26, 2021
By: Kaitlyn Grosse

News

Seattle Startup Lumen Biosciences to Build Algae Manufacturing Plant in Former Bakery

Posted onJuly 19, 2021 Last Updated: July 19, 2021
By: Kaitlyn Grosse

News

Seattle-Based Icosavax, Which is Developing COVID-19 Vaccines, Files for IPO 4 Years After Launch

Posted onJuly 19, 2021 Last Updated: July 19, 2021
By: Kaitlyn Grosse

News

Absci’s IPO Reflects Booming Biotech Market and Growing PNW Life Sciences Industry

Posted onJuly 12, 2021 Last Updated: July 12, 2021
By: Kaitlyn Grosse

News

Report: Seattle’s Life Sciences Industry Continues to Boom

Posted onJuly 12, 2021 Last Updated: July 12, 2021
By: Kaitlyn Grosse